6月18日，宋城演艺（300144.SZ，股价8.78元，市值230.27亿元）发布公告称，公司于近日收到中国证 券监督管理委员会浙江监管局（以下简称"浙江证监局"）出具的《关于对宋城演艺发展股份有限公司及 相关人员采取出具警示函措施的决定》（以下简称"警示函"）。 浙江证监局认为，该行为违反了《上市公司信息披露管理办法》的相关规定，决定对公司及公司董事长 张娴、总裁商玲霞、财务总监陈胜敏、董事会秘书赵雪璎分别采取出具警示函的监管措施，并记入证券 期货市场诚信档案。 《每日经济新闻》记者获悉，2023年，宋城演艺的联营企业Huafang Group Inc.（花房集团）有一家参 股25%的公司被警方调查，导致花房集团无法向宋城演艺提供经核数师审核的年度业绩。宋城演艺的年 审会计师因此对公司2022年度财务报表发表了保留意见。2024年3月，花房集团在其2022年度原有的合 并报表基础上追加确认了1.55亿元预计损失和约1991万元投资公允价值损失，使得宋城演艺需要同步大 幅更正2022年财报。 记者了解到，花房集团为宋城演艺参股35.35%的联营企业，主要从事音视频直播娱乐及社交网络服 务。宋城演艺是花房集团 ...

克雷西 发自 凹非寺 量子位 | 公众号 QbitAI 奥特曼抓马的宫斗大戏，这下真的成drama了 。 The Hollywood Reporter消息，米高梅计划联手意大利知名导演 卢卡·瓜达尼诺 （Luca Guadagnino） ，将OpenAI高层的争斗翻拍成电 影。 该片名为 《Artificial》 ，米高梅计划今年夏天就开拍，正在和瓜达尼诺积极洽谈。 看到这个消息，网友们开始疯狂cue起了2010年的电影 《社交网络》 （《The Social Network》） ，该电影讲述了扎克伯格的Facebook创 业史。 还有网友表示，剧组很可能希望蜘蛛侠的扮演者、在《社交网络》中扮演Facebook联创萨维林 （Eduardo Saverin） 的 安德鲁·加菲尔德 （Andrew Garfield） 能来扮演奥特曼。 而手更快些的网友，已经把奥特曼电影的结局给安排上了 。 △ 图为电影《社交网络》中剧情 蜘蛛侠扮演者或出演奥特曼 除了意向导演瓜达尼诺之外，The Hollywood Reporter还爆料了《Artificial》的几名制片人。 其中包括将哈利波特改编成八部电影的知名制片人 大卫 ...

Doximity (DOCS) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 40.74%. A quarter ago, it was expected that this medical social networking site would post earnings of $0.33 per share when it actually produced earnings of $0.45, delivering a surprise of 36.36%.Over the last four quarte ...

Core Viewpoint - Progyny reported quarterly earnings of $0.48 per share, exceeding the Zacks Consensus Estimate of $0.45 per share, and showing an increase from $0.39 per share a year ago, indicating a positive earnings surprise of 6.67% [1] - The company also posted revenues of $324.04 million for the quarter, surpassing the Zacks Consensus Estimate by 6.60% and up from $278.08 million year-over-year [2] Financial Performance - Over the last four quarters, Progyny has consistently surpassed consensus EPS estimates, achieving this four times [2] - The company has also topped consensus revenue estimates two times in the same period [2] - Progyny shares have increased by approximately 35.8% since the beginning of the year, contrasting with a -4.3% decline in the S&P 500 [3] Future Outlook - The sustainability of the stock's price movement will largely depend on management's commentary during the earnings call and the company's earnings outlook [3][4] - Current consensus EPS estimate for the upcoming quarter is $0.42 on revenues of $306.87 million, and for the current fiscal year, it is $1.62 on revenues of $1.21 billion [7] Industry Context - The Medical Services industry, to which Progyny belongs, is currently ranked in the top 22% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Progyny's stock performance [5]